{"id":"W2765212556","doi":"10.1016/j.jval.2017.08.1922","title":"A Retrospective Claims Analysis on Rates of Compliance and Discontinuation Among Canadian Multiple Sclerosis Patients Treated with Disease-Modifying Therapies at 6, 12 and 24-Month Periods","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Notre-Dame; University of Calgary; Novartis (Canada)","funders":"","keywords":"Natalizumab; Discontinuation; Teriflunomide; Medicine; Fingolimod; Glatiramer acetate; Internal medicine; Medical prescription; Retrospective cohort study; Multiple sclerosis; Physical therapy; Disease; Pharmacology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001217198,0.0001406385,0.0003953327,0.0002286982,0.00044519,0.00003812936,0.00004660905,0.0000493419,0.000006107999],"category_scores_gemma":[0.00007648336,0.0001008741,0.0000441645,0.0001413538,0.0002428519,0.0001048258,0.00001795,0.00009817541,3.61472e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002901709,"about_ca_system_score_gemma":0.0001288279,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3636064,"about_ca_topic_score_gemma":0.1734106,"domain_scores_codex":[0.9989926,0.00007673333,0.0002255929,0.0002932244,0.0001685805,0.0002432786],"domain_scores_gemma":[0.9989637,0.00004275973,0.0002477837,0.000276391,0.00005792507,0.0004114023],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005556537,0.0001293002,0.9966592,0.00009021962,0.0001745788,0.000005665825,0.0009900141,0.0001433338,0.0000147846,0.00001619587,0.000006054109,0.001215034],"study_design_scores_gemma":[0.002300548,0.0004264023,0.9821327,0.00116471,0.000186478,2.366365e-7,0.0001310923,0.0135159,0.00002593521,0.00001312861,0.000004675488,0.00009822945],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973776,0.001395881,0.000001823095,0.0004093054,0.00001965472,0.0005287787,0.0001863108,0.00001013473,0.00007048059],"genre_scores_gemma":[0.9989923,0.0007204433,0.0000524049,0.00006021123,0.00001140683,0.00002034937,0.00006202835,0.00001402829,0.00006678812],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1901958,"threshold_uncertainty_score":0.8416725,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07298604935886653,"score_gpt":0.3027775360402757,"score_spread":0.2297914866814091,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}